Proven, Trusted Investors in Healthcare Innovation
With over two decades of experience as early stage VC company builders, Hatteras Venture Partners has constructed a risk-mitigated, replicable value creation model. The cutting-edge companies we focus on range from those delivering therapeutic or diagnostic benefits to patients to companies disrupting the status quo in healthcare and accelerating the pace of innovation.
Our Continuum of Investments
Transformative Therapies
A drug which hits a pathway.
FDA Regulation:
High
Investment Type Example:
Rodin is developing a differentiated approach to Alzheimer’s through targeted epigenetic regulation of synaptic function and health by HDAC complex modulation.
A transformational platform that generates therapies
FDA Regulation:
Medium
Investment Type Example:
Based on research from UNC-Chapel Hill, Ribometrix is building a technology platform that enables RNA to be targeted with small molecules.
A platform driving efficiency in healthcare.
FDA Regulation:
None
Investment Type Example:
NurseGrid employs a bottom-up, mobile-first solution through a free app for seamless scheduling and shift management for nurses and health techs.
Disruptive Technologies
A drug which hits a pathway.
FDA Regulation:
High
A transformational platform that generates therapies.
FDA Regulation:
Medium
A platform driving efficiency in healthcare.
FDA Regulation:
None
Creating Value in Proven Sectors
Our portfolio represents the following proven yet burgeoning sectors.
Biopharma
• Building transformative therapeutic pipelines and platform technologies
• Involved from pre-clinical stage
Learn More
Med Devices
• Open to disruptive devices of all classes
• At least early prototype stage
Learn More
Diagnostics
• Empowering advances in patient care
• Regulatory path agnostic
Learn More
Healthcare IT/ Other
• Enabling value driven care and consumerism
• Early but at a post revenue stage
Learn More
Investing Nationally
While Hatteras Venture Partners is a recognized leader in the Southeast, our investments reflect markets with attractive dynamics nationwide.
California
GreyBug Inc.
Qpex
SpineAlign
Trefoil Therapeuitics, Inc.
Wildflower Health Inc.
Colorado
Dropworks
Connecticut
Artizan Biosciences, Inc.
Florida
BlinkBio (fka Coferon Inc.)
Georgia
Clearside Biomedical
Massachusetts
Boston Immune Technologies
Curoverse Inc.
Genturi, Inc.
Kymera
Lysosomal Therapeutics Inc.
ORIG3N Inc.
Rodin Therapeutics, Inc.
Sideris Pharmaceuticals Inc.
Michigan
HistoSonics
North Carolina
ArtusLabs
Bivarus, Inc.
CancerGuide Diagnostics
Clinipace
Clinverse Inc.
Contego Medical LLC
Entegrion (Cooper Secondary)
G1 Therapeutics Inc.
GeneCentric
Innocrin Pharmaceuticals
KinoDyn Inc.
Medfusion, Inc.
NeuroTronik Inc.
Respirics (Cooper Secondary)
Ribometrix, Inc.
Spyryx Biosciences Inc.
StrideBio, Inc.
Viamet Pharmaceuticals
New York
Medikidz Inc. / dba Jumo Health
Ohio
Standard Bariatrics, Inc.
Oregon
NurseGrid
Pennsylvania
Embrella Cardiovascular
PhaseBio Pharmaceuticals
TetraLogic
Tennessee
Device Innovation Group
NuSirt Biopharma Inc.
Pathfinder
Texas
Elligo Health Research, Inc.
Ontario
Qvella Corporation